Samsung Electronics (LON:BC94) subsidiary NeuroLogica said today that it inked a distribution deal with MaxQ AI to integrate its artificial intelligence software with NeuroLogica’s medical imaging tech in the U.S. and EU’s acute care marketplace. Through the deal, NeuroLogica said that it will offer MaxQ’s Accipio IX, part of the AI-company’s FDA-cleared and CE Mark approved […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
FDA extends decision date for Sage’s postpartum depression injection
Sage Therapeutics (NSDQ:SAGE) said today that the FDA extended its decision date for Sage’s Zulresso brexanolone injection to March 19, 2019. The U.S. regulatory agency was previously slated to decide whether or not to approve the drug as a treatment for postpartum depression by Dec. 19. Get the full story at our sister site, Drug Delivery […]
Nico raises $13m Series B for neurosurgery devices
Nico Corp. said today that it raised nearly $13 million in a Series B round from a group of existing backers for its line of neurosurgery devices. Indianapolis-based Nico said the $12.5 million round is earmarked for new product development and commercialization, clinical and economic studies, growing its sales and clinical teams, and expanding its footprint […]
Cerus Endovascular starts European trial of intracranial aneurysm device
Cerus Endovascular said it has enrolled the first patients in a study designed to assess the safety of the company’s Contour neurovascular system, which is designed to reduce the risk of rupture when treating patients with intracranial aneurysms. Intracranial aneurysms occur at the rate of nine per 100,000 with a wide range; in some countries, the rate is […]
Aquestive wins FDA nod for seizure oral film
Shares in Aquestive Therapeutics (NSDQ:AQST) rose today after the company announced FDA approval for its Sympazan oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome. The clobazam oral film is the first product of its kind to be approved by the FDA as a treatment for seizures associated with LGS, according to Aquestive. Clobazam […]
NIH invests over $220M in BRAIN initiative
The National Institutes of Health announced today that it is funding more than 200 new awards, totaling over $220 million in investments, through the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. Some of the new awards include the creation of a wireless optical tomography cap for scanning human brain activity; a noninvasive brain-computer interface […]
Abiomed joins Protembis $10m Series A
Protembis said today it closed a $10 million Series A round, joined by cardiovascular device-focused Abiomed (NSDQ:ABMD), to support its embolic cerebral protection device. The round was joined by Abiomed, Aachen and Mönchengladbach GmbH’s Seed Fonds III and a number of family offices and angel investors, the Aachen, Germany-based company said. “Patient safety should always be our […]
The top 10 medical disruptors of 2019
The Cleveland Clinic for the past 16 years has predicted what the top 10 medical disruptors will be for the following year. The health provider seeks input from 150 to 200 of its physicians, hailing from each of its institutes. The result is 300 to 400 suggestions, which the clinic then narrows down to 150. […]
Novocure touts results from glioblastoma TTF trial analysis
NovoCure (NSDQ:NVCR) yesterday released results from a post-hoc analysis of its EF-14 phase 3 pivotal trial in newly diagnosed glioblastoma, touting an association between higher doses of Tumor Treating Fields and improved overall survival. The analysis explored patient data from 317 qualified individuals in the TTF treatment arm of the St. Helier, Jersey-based company’s EF-14 phase […]
Monteris wins FDA nod for NeuroBlate Optic laser probe
Monteris Medical said today it won FDA clearance for the NeuroBlate Optic laser probe designed for its minimally invasive magnetic resonance imaging-guided NeuroBlate robotic laser thermotherapy system, which is intended for use in treating brain tumors and epileptic foci. The Plymouth, Minn.-based company said that the newly cleared laser probe replaces previous generation’s metal thermocouple inside […]
Feinstein researchers study what the body is telling the brain
A 2014 study showed that inflammation-causing proteins known as cytokines were present in the plasma of lupus patients up to several weeks before their disease flared up. Conversely, these Oklahoma researchers found that inflammation regulators are present during periods when the disease is stable. Now, researchers at The Feinstein Institute for Medical Research (Manhasset, N.Y.) are working […]